VitriVax, Inc.
PrivateLast Round
Series B
Oct 22, 2025
Total Funding Raised
$80.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VitriVax, Inc. is a biotechnology company that develops a vaccine formulation platform (ALTA®) designed to enable thermostable, single-shot administration of vaccines and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VitriVax, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
VitriVax, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 22, 2025 | ||||
| Grant | Oct 14, 2025 | ||||
| Grant | Sep 14, 2025 | ||||
| Grant | Apr 28, 2025 | ||||
| Grant | Dec 4, 2024 | ||||
Grant | Dec 6, 2023 |
Key People
Founding team and executive leadership
VitriVax, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| CEPI | Grant |
| Gates Family Foundation | Grant |
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Adjuvant Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 291% MoM.
- Oct 22, 2025
$17.25M round closed.
VitriVax, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VitriVax, Inc.'s valuation, stock price, and market status.